Tag - PacBio

2023: Ozempic, 2nd Biggest Bank Collapse, AlphaFold, FDA Approval of Gene Therapy and CRISPR Gene Editing,….

A Complete Y chromosome Sequence – Represents over 180,000 Years of Evolution of the Human Y Sequence

The Cheap Genome Is Not Enough – We Need an “Accurate and Good Genome”

2021 – Precision Medicine linked with Genomic Medicine: A Work in Progress

Pacific Biosciences Closes Acquisition of Omniome and Establishes San Diego Presence

Pacific Biosciences Acquires Circulomics – A Leading High Molecular Weight DNA Extraction Company

Pacific Biosciences Signs Definitive Agreement to Acquire Omniome

Pacific Biosciences and RCIGM Announce its First Collaboration for Whole Genome Sequencing Research

AGBT 2021 – A Virtual Summary with Spatial Profiling Dominating

Human Pangenome Reference Consortium Announced Global Release of Year 1 Sequencing Data

Pacific Biosciences Sequel II Systems Deployed to Scale-Up Global Viral Surveillance Initiatives Focused on COVID-19

Enlightenbio Releases New Clinical Genomics Report: The Interplay Between Clinical Research & Clinical Diagnostics

Pacific Biosciences Announces $900 Million Investment from SoftBank to Support Growth Initiatives

Pacific Biosciences and Invitae to Develop Ultra-High-Throughput Clinical Whole Genome Sequencing Platform

2020 Was Not Just About COVID-19

Leading UK Core Labs Expand Investment in PacBio Sequencing Systems to Power Life Science Research with HiFi Reads

Copyright © 2026. enlighenbio LLC. All rights reserved.